-
1
-
-
8244258025
-
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
-
1. Brain E, Garrino C, Misset JL, Carbonero IG, Itzaki M, Cvitkovic E, et al. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer 1997; 75: 1360-7.
-
(1997)
Br J Cancer
, vol.75
, pp. 1360-1367
-
-
Brain, E.1
Garrino, C.2
Misset, J.L.3
Carbonero, I.G.4
Itzaki, M.5
Cvitkovic, E.6
-
2
-
-
0030838587
-
Clinical and pathological response to primary chemotherapy in operable breast cancer
-
2. Chollet P, Charrier S, Brain E, et al. Clinical and pathological response to primary chemotherapy in operable breast cancer. Eur J Cancer 1997; 33: 862-6.
-
(1997)
Eur J Cancer
, vol.33
, pp. 862-866
-
-
Chollet, P.1
Charrier, S.2
Brain, E.3
-
3
-
-
0022616845
-
Pathological assessment of response to induction chemotherapy in breast cancer
-
3. Feldman LD, Hortobagyi GN, Budzar AU, Ames SC, Blumenschein GR. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986; 46: 2578-81.
-
(1986)
Cancer Res
, vol.46
, pp. 2578-2581
-
-
Feldman, L.D.1
Hortobagyi, G.N.2
Budzar, A.U.3
Ames, S.C.4
Blumenschein, G.R.5
-
4
-
-
0344043450
-
Primary chemotherapy in breast cancer: Correlation between tumor response and patient outcome
-
4. Ferriere JP, Assier I, Cure H, et al. Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome. Am J Clin Oncol 1998; 21: 117-20.
-
(1998)
Am J Clin Oncol
, vol.21
, pp. 117-120
-
-
Ferriere, J.P.1
Assier, I.2
Cure, H.3
-
5
-
-
0031975835
-
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer
-
5. Honkoop AH, van Diest PJ, de Jong JS, et al. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer 1998; 77: 621-6.
-
(1998)
Br J Cancer
, vol.77
, pp. 621-626
-
-
Honkoop, A.H.1
Van Diest, P.J.2
De Jong, J.S.3
-
6
-
-
0026353083
-
Preoperative chemotherapy in primarily inoperable cancer of the breast
-
6. Luboinski G, Nagadowska M, Pieńkowski T. Preoperative chemotherapy in primarily inoperable cancer of the breast. Eur J Surg Oncol 1991; 17: 603-7.
-
(1991)
Eur J Surg Oncol
, vol.17
, pp. 603-607
-
-
Luboinski, G.1
Nagadowska, M.2
Pieńkowski, T.3
-
7
-
-
0026507925
-
Neoadjuvant chemotherapy in 126 operable breast cancers
-
7. Belembaogo E, Feillel V, Chollet P, Cure H, Verrelle P, Kwiatkowski F. Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer 1992; 28A: 896-900.
-
(1992)
Eur J Cancer
, vol.28 A
, pp. 896-900
-
-
Belembaogo, E.1
Feillel, V.2
Chollet, P.3
Cure, H.4
Verrelle, P.5
Kwiatkowski, F.6
-
8
-
-
70449185514
-
Histological grading and prognosis in breast cancer
-
8. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-77.
-
(1957)
Br J Cancer
, vol.11
, pp. 359-377
-
-
Bloom, H.J.G.1
Richardson, W.W.2
-
9
-
-
0026315005
-
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy
-
9. Bonadonna G, Valagussa P, Brambilla C, Moliterni A, Zambetti M, Ferrari L. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. Sem Oncol 1991; 18: 515-24.
-
(1991)
Sem Oncol
, vol.18
, pp. 515-524
-
-
Bonadonna, G.1
Valagussa, P.2
Brambilla, C.3
Moliterni, A.4
Zambetti, M.5
Ferrari, L.6
-
10
-
-
9044244912
-
Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer: Long-term results
-
10. Colozza M, Gori S, Mosconi AM, et al. Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer: long-term results. Am J Clin Oncol Cancer Clin Trials 1996; 19: 10-7.
-
(1996)
Am J Clin Oncol Cancer Clin Trials
, vol.19
, pp. 10-17
-
-
Colozza, M.1
Gori, S.2
Mosconi, A.M.3
-
11
-
-
8044260251
-
A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer
-
11. Ferrero JM, Namer M, Dufour JF, et al. A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer. Bull Cancer 1997; 84: 10-6.
-
(1997)
Bull Cancer
, vol.84
, pp. 10-16
-
-
Ferrero, J.M.1
Namer, M.2
Dufour, J.F.3
-
12
-
-
0002007546
-
Inflammatory breast cancer: Intensive chemotherapy (FEC-BC) results in a high histologic complete response rate
-
12. Chevallier B, Roche H, Olivier JP, Hurteloup P. Inflammatory breast cancer: intensive chemotherapy (FEC-BC) results in a high histologic complete response rate. Proc ASCO 1990; 9: 42-9.
-
(1990)
Proc ASCO
, vol.9
, pp. 42-49
-
-
Chevallier, B.1
Roche, H.2
Olivier, J.P.3
Hurteloup, P.4
-
13
-
-
0027262410
-
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate
-
13. Chevallier B, Roche H, Olivier JP, Chollet P, Hurteloup P. Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 1993; 16: 223-8.
-
(1993)
Am J Clin Oncol
, vol.16
, pp. 223-228
-
-
Chevallier, B.1
Roche, H.2
Olivier, J.P.3
Chollet, P.4
Hurteloup, P.5
-
14
-
-
0031036948
-
Effects of chemotherapy on pathologic and biologic characteristic of locally advanced breast cancer
-
14. Honkoop AH, Pinedo HM, de Jong JS, et al. Effects of chemotherapy on pathologic and biologic characteristic of locally advanced breast cancer. Am J Clin Pathol 1997; 107: 211-8.
-
(1997)
Am J Clin Pathol
, vol.107
, pp. 211-218
-
-
Honkoop, A.H.1
Pinedo, H.M.2
De Jong, J.S.3
-
15
-
-
0009483055
-
Neoadjuvant chemotherapy (NCT) in locally advanced breast cancer (LABC) stage III. Clinical and histopathological (HP) evaluation
-
15. Marantz A, Pascoon G, Gerowich G, Litowska S. Neoadjuvant chemotherapy (NCT) in locally advanced breast cancer (LABC) stage III. Clinical and histopathological (HP) evaluation. Proc Annu Meet Am Soc Oncol 1989; 8A: 119.
-
(1989)
Proc Annu Meet Am Soc Oncol
, vol.8 A
, pp. 119
-
-
Marantz, A.1
Pascoon, G.2
Gerowich, G.3
Litowska, S.4
|